AQST
NASDAQ · Pharmaceuticals
Aquestive Therapeutics Inc
$3.98
-0.08 (-1.97%)
Open$4.04
Previous Close$4.06
Day High$4.14
Day Low$3.96
52W High$7.55
52W Low$2.12
Volume—
Avg Volume2.28M
Market Cap519.73M
P/E Ratio—
EPS$-0.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+550.8% upside
Current
$3.98
$3.98
Target
$25.90
$25.90
$17.61
$25.90 avg
$34.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 83.52M | 80.13M | 128.94M |
| Net Income | -64,041,713 | -55,298,418 | 33.13M |
| Profit Margin | -76.7% | -72.9% | 25.7% |
| EBITDA | -51,532,878 | -46,969,427 | 53.66M |
| Free Cash Flow | — | — | 23.71M |
| Rev Growth | +4.2% | +4.2% | +19.1% |
| Debt/Equity | 4.68 | 4.68 | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |